SLDB Cash Ratio
5.58TTM
Retrieved:
SLDB FY Cash Ratio
6.920.00
2015-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
SLDB cash ratio history
Cash divided by current liabilities. The available annual fiscal periods series contains 11 observations from Dec 31, 2015 to Dec 31, 2025.
| Period ending | Cash Ratio |
|---|---|
| 1.7896 | |
| 2.6518 | |
| 5.0985 | |
| 6.9035 | |
| 5.0479 | |
| 6.3212 | |
| 4.1608 | |
| 6.9198 | |
| 4.6207 | |
| 1.1171 | |
| 2.0536 |
Compare cash ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) cash ratio
- Bridgebio Pharma Inc (BBIO) cash ratio
- Brightspring Health Services Inc (BTSG) cash ratio
- Madrigal Pharmaceuticals Inc (MDGL) cash ratio
- Ensign Group Inc (ENSG) cash ratio
- Glaukos Corp (GKOS) cash ratio
- Vaxcyte Inc (PCVX) cash ratio
- Krystal Biotech Inc (KRYS) cash ratio
Compare all covered stocks by cash ratio →
All SLDB financial metrics · SLDB stock overview · How to interpret financial metrics
